Ftse Mib
34.396,01
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
64.751,01
-0,16%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
23/10/201722:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
23/10/201714:46Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
19/10/201723:29Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BPMXBioPharmX Corporation
18/10/201716:30PR Newswire (US)BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017AMEX:BPMXBioPharmX Corporation
11/10/201716:30PR Newswire (US)BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Dru...AMEX:BPMXBioPharmX Corporation
13/09/201722:05Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
13/09/201715:00PR Newswire (US)BioPharmX Reports Second Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
12/09/201713:30PR Newswire (US)BioPharmX Announces Preliminary Data from Rosacea Feasibility StudyAMEX:BPMXBioPharmX Corporation
05/09/201715:15PR Newswire (US)BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment ConferenceAMEX:BPMXBioPharmX Corporation
28/08/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
17/08/201722:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
08/08/201720:43Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
03/08/201723:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
27/07/201715:15PR Newswire (US)Summer AAD Panel to Discuss BPX-01 for Acne and RosaceaAMEX:BPMXBioPharmX Corporation
24/07/201712:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
13/07/201715:15PR Newswire (US)BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017AMEX:BPMXBioPharmX Corporation
22/06/201715:15PR Newswire (US)BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer SymposiumAMEX:BPMXBioPharmX Corporation
14/06/201715:00PR Newswire (US)BioPharmX Invited to Present at World Preclinical CongressAMEX:BPMXBioPharmX Corporation
13/06/201722:05PR Newswire (US)BioPharmX Reports First Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
07/06/201712:15PR Newswire (US)BioPharmX to Report First Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
05/06/201722:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
01/06/201714:15PR Newswire (US)BioPharmX Advances BPX-01 2% Upon Achieving Statistical Significance for Primary EndpointAMEX:BPMXBioPharmX Corporation
11/05/201715:25PR Newswire (US)BioPharmX to Host "State of Acne" Symposium on June 1AMEX:BPMXBioPharmX Corporation
03/05/201722:05PR Newswire (US)BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for AcneAMEX:BPMXBioPharmX Corporation
01/05/201722:39Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/04/201722:15PR Newswire (US)BioPharmX Announces Closing of $5.0 Million OfferingAMEX:BPMXBioPharmX Corporation
26/04/201715:00PR Newswire (US)BioPharmX Announces $5.0 Million OfferingAMEX:BPMXBioPharmX Corporation
21/04/201722:34Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BPMXBioPharmX Corporation
21/04/201722:24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/04/201715:15PR Newswire (US)BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2...AMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

LSE
SPLT
Ishs Platinum �
NYSE
MTRN
Materion
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network